NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
Wyeth »01/10/2009 [Company watch]
China Requires One Divestiture for Pfizer / Wyeth Merger

The Anti-Monopoly Bureau of China’s Ministry of Commerce ((MOFCOM)) has given its okay to the merger between Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE). However, MOFCOM will require that Pfizer divest its swine mycoplasmal pneumonia vaccine business. Pfizer has been negotiating with the Anti-Monopoly Bureau on the ruling, implying that it will not be surprised by the ruling, even if it may not agree.

 
The Anti-Monopoly Bureau of China’s Ministry of Commerce ((MOFCOM)) has given its okay to the merger between Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE). However, MOFCOM will require that Pfizer divest its swine mycoplasmal pneumonia vaccine business. Pfizer has been negotiating with the Anti-Monopoly Bureau on the ruling, implying that it will not be surprised by the ruling, even if it may not agree. According to the MMLC Group (mmlcgroup.com), the decision from the relatively young Anti-Monopoly Group was short, but very clear in its discussion of administrative law and guidelines. That helps observers in their understanding of how the Anti-Monopoly Group goes about fulfilling its duties. Previous opinions, apparently, left observers wondering how the Group arrived at its conclusions. What was not particularly clear, following the decision, was how the Wyeth merger would affect Pfizer’s position in the swine pneumonia vaccine sector. Granted, Pfizer is a significant presence in the business, but Wyeth did not appear to increase its strength in the market.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.